All filters
Abstracts
Amphetamine-type stimulant use is common and associated with HIV infection among MSM and TGW in Bangkok, Thailand
D. Colby Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Pediatric disclosure of HIV status and effect on mortality and LTFU among children and adolescents living with HIV in Asia
J. Sornillo, Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Psychosocial Risk Factors and Cognitive Decline in People Living with HIV: Results from the Malaysian HIV and Aging (MHIVA) Study
M. Neelamegam Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Self-sampled specimens demonstrate comparable sensitivity and specificity to clinician-sampled specimens for HPV detection among MSM in China
Y. Lu Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Abstracts
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfected Patients Through 96 Weeks
Y Huang Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021
Meeting
APACC 2022
16 Jun 2022 - 18 Jun 2022
Virtual Meeting
Videos
Russian HIV Clinical Series | Roundtable Discussion | 3rd Edition | 13 May
Presented at:
Russian HIV Clinical Series 2021
Videos
Long acting (LA) drug delivery in TB treatment | Andrew Owen, BSS, MSC, PhD, FSB
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Lost in translation: learning from preclinical data | Gerry Davies
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Charles Peloquin, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
A new model for early clinical development of TB drugs and its application to Q203 and BTZ043 | Norbert Heinrich, MD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Videos
Russian HIV Clinical Series | Natalia Litvinova | 2nd Edition | 15 April
Presented at:
Russian HIV Clinical Series 2021
Videos
Benefits of data collaboration – personalized tailoring regimens | Rada Savic, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Videos
Searching for a Universal Regimen for Tuberculosis Treatment with a Shorter Duration of Therapy | Khisi Mdluli, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
CPK/PD Support for a Phase 1 Study of TBA-7371- Jerry Nedelman, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Bedaquiline appears to antagonize its own main metabolite’s QTcF interval prolonging effect- Lénaïg Tanneau, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
TPreclinical and Clinical Pharmacokinetics and Pharmacodynamics Analysis of Delamanid- Suresh Mallikaarjun, PHD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Translational pharmacokinetic modelling & simulation of an experimental long-acting injectable formulation of bedaquiline- An Vermeulen, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018
Slidesets
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention- Anthony Podany, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2018